
成都格利普生物科技有限公司
成都格利普生物科技有限公司
Main Products:Triterpenol, Piperine triterpene piperidine 107584-38-3 reference standard supply, Hydroxyemodin 481-73-2 Reference Standard Supply,
View moreAbout Us
Contact Supplier
Hot Products
+ moreCompany Profile
+ more
Chengdu Gelip Biological Technology Co., Ltd. is a national high-tech enterprise and CNAS-certified laboratory specializing in the research, development, production, testing, and sales of reference standards, traditional Chinese medicine reference standards, standard substances, natural plant compound extraction, and pharmaceutical raw materials. The company boasts comprehensive regulations, a well-structured team, and advanced experimental equipment.
Chengdu Gelip Biological Technology Co., Ltd. offers end-to-end services from the extraction of traditional Chinese medicine extracts to the research, development, and purification of chemical reference standards. The company is located in the Cross-Strait Science and Technology Park in Wenjiang District, Chengdu, Sichuan Province, with its extraction production base situated in Luoshui Town, Shifang City, known as the "Pearl of Western Sichuan." The production facility covers an area of 3,000 square meters, including pre-processing workshops, extraction workshops, and active pharmaceutical ingredient (API) refining and packaging workshops. The natural product separation laboratory, located in the Cross-Strait Science and Technology Park, spans 500 square meters and is set in a beautiful environment, just 800 meters from Chengdu University of Traditional Chinese Medicine. The laboratory includes separation and purification labs, raw and auxiliary material rooms, precision instrument testing rooms, and product sample storage rooms. Equipped with advanced testing instruments such as high-performance liquid chromatography (HPLC), ultraviolet spectrophotometers, and moisture analyzers, the company ensures comprehensive and effective product quality control. Production equipment incorporates partial automation, enhancing mechanization and transforming traditional labor-intensive extraction methods. By focusing on centralized, large-scale, and standardized production of plant-based APIs, leveraging its extensive technical expertise and resource reserves, and adhering to domestic process and quality standards, the company effectively reduces production costs while ensuring product quality stability.
The company is well-established, with robust management and abundant resource reserves. As production and sales continue to grow, economic benefits improve, and scale expands, it has strengthened close collaborations with domestic medical universities and research institutions (e.g., Chengdu University of Traditional Chinese Medicine, Sichuan Agricultural University, West China School of Medicine, China Pharmaceutical University, and Kunming Institute of Botany). With strong product and technological development capabilities, the company possesses significant technical reserves and experience in the research, production, and innovation of traditional Chinese medicine natural products, mastering advanced theoretical principles and implementation methods. It focuses on the in-depth development of new varieties, expanding application markets, and promoting the industrialization of traditional Chinese medicine natural product research. By leveraging complementary advantages, expanding sales markets, and fostering social division of labor in the traditional Chinese medicine pharmaceutical industry, the company remains committed to its operational philosophy of meeting customer needs. Adhering to customer demands and market trends, it continuously develops high-quality new products, improves comprehensive service quality to satisfy society and customers, creates value for society, and strives tirelessly to achieve customer satisfaction.